代谢综合征与胃癌发生发展的相关性研究

唐嘉黛; 谢琳; 宋红莉; 陈娇娇

doi:10.12259/j.issn.2095-610X.S20211130

代谢综合征与胃癌发生发展的相关性研究

doi: 10.12259/j.issn.2095-610X.S20211130

云南省肿瘤医院/昆明医科大学第三附属医院消化肿瘤内科，云南昆明　650118

基金项目: 国家自然科学基金资助项目（81760520）；昆明医科大学研究生创新基金资助项目（2021S253）

详细信息

作者简介:
唐嘉黛（1995～），女，云南昆明人，在读硕士研究生，主要从事消化肿瘤内科临床工作

通讯作者:
谢琳，E-mail：xielinyanghan@163.com

中图分类号: R735
计量
- 文章访问数: 4761
- HTML全文浏览量: 2341
- PDF下载量: 24
- 被引次数: 0
出版历程
- 收稿日期: 2021-10-10
- 网络出版日期: 2021-11-16
- 刊出日期: 2021-11-30

Correlation between Metabolic Syndrome and the Occurrence and Development of Gastric Cancer

Dept. of Gastrointestinal Oncology，The 3rd Affiliated Hospital of Kunming Medical University/Tumor Hospital of Yunnan Pronvince，Kunming Yunnan 650118，China

摘要

摘要: 胃癌是世界范围内发病率和死亡率均排行第二位的恶性肿瘤，严重威胁人类健康。近年，以胰岛素抵抗为核心的一组代谢紊乱症候群—代谢综合征（metabolic syndrome，Mets）与GC（gastric cancer，GC）的关系备受瞩目，大量研究表明Mets中各因素及其合并症均可以影响GC的发生、发展，可能机制包括高血糖、肥胖、胰岛素因子等单或多方面因素协同作用。旨在围绕近年相关研究，从流行病学、发病机制等方面综述MetS各项代谢相关因素及合并症与GC的关联。
- 胃癌 /
- 代谢综合征 /
- 肥胖 /
- 血脂 /
- 2型糖尿病 /
- 高血压
Abstract: Gastric cancer is the second most common malignant tumor in the world in terms of morbidity and mortality. It is a serious threat to human health.In recent years, with insulin resistance as the core of a group of metabolic disorder syndrome - the metabolic syndrome （metabolic syndrome, MetS） and the relationship between gastric cancer high-profile, a large number of studies had shown that various factors in the MetS and its complications could affect the occurrence and development of gastric cancer, the possible mechanism including hyperglycemia, obesity, insulin factors such as single or multiple factors synergy, this article aims to surrounding related research in recent years, were reviewed from aspects of the epidemiology, the pathogenesis of various metabolic factors associated with MetS and complications associated with stomach cancer.
- Gastric cancer /
- Metabolic syndrome /
- Obesity /
- Hyperlipidemia /
- Type 2 diabetes /
- Hypertension

HTML全文

参考文献(40)

[1]	郑潇豪,解亦斌. 中国晚期胃癌的诊疗现状[J]. 癌症进展,2019,17(1):19-25+54.
[2]	Siegel R L,Miller K D,Jemal A. Cancer statistics,2020[J]. CA Cancer J Clin,2020,70(1):7-30. doi: 10.3322/caac.21590
[3]	Liberda E N,Zuk A M,Martin I D,et al. Fisher's linear discriminant function analysis and its potential utility as a tool for the assessment of health-and-wellness programs in indigenous communities[J]. Int J Environ Res Public Health,2020,17(21):7894. doi: 10.3390/ijerph17217894
[4]	Battelli M G,Bortolotti M,Polito L,et al. The role of xanthine oxidoreductase and uric acid in metabolic syndrome[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(8):2557-2565. doi: 10.1016/j.bbadis.2018.05.003
[5]	Wang Z,Cai X J,Liu M J,et al. Age,gender and type 2 diabetes contribute to the risk of gastric cancer:a retrospective single institution analysis[J]. J Chin Pharm Sci,2014,23(11):799-803.
[6]	Bloomgarden Z. Diabetes and branched-chain amino acids:what is the link?[J]. J Diabetes,2018,10(5):350-352. doi: 10.1111/1753-0407.12645
[7]	陈燕. 肥胖预防与消化道肿瘤关系[J]. 心理医生,2017,23(30):329-330.
[8]	Shimada S,Sawada N,Ishiyama Y,et al. Impact of obesity on short- and long-term outcomes of laparoscopy assisted distal gastrectomy for gastric cancer[J]. Surg Endosc,2018,32(1):358-366. doi: 10.1007/s00464-017-5684-9
[9]	Du X,Hidayat K,Shi B M. Abdominal obesity and gastroesophageal cancer risk:systematic review and meta-analysis of prospective studies[J]. Bioscience Reports,2017,37(3):BSR20160474. doi: 10.1042/BSR20160474
[10]	Lin X H,Huang K H,Chuang W H,et al. The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy[J]. PLoS ONE,2018,13(11):e0206930. doi: 10.1371/journal.pone.0206930
[11]	Kumar S,Metz D C,Ellenberg S,et al. Risk factors and incidence of gastric cancer after detection of helicobacter pylori Infection:a large cohort study[J]. Gastroenterology,2020,158(3):527-536. doi: 10.1053/j.gastro.2019.10.019
[12]	梁晓峰,李利娟,刘俊田. 代谢综合征与胃癌发病风险及临床病理特征相关性的研究[J]. 中国肿瘤临床,2019,46(19):986-993. doi: 10.3969/j.issn.1000-8179.2019.19.090
[13]	刘兆喆,邱诗晴,郭放,等. 体质量指数对胃癌预后影响[J]. 临床军医杂志,2017,45(1):20-23.
[14]	韩帮岭,汪亦民,薛英威. 体质指数与胃癌患者临床病理特征和预后的关系[J]. 中华肿瘤杂志,2019,41(7):527-532.
[15]	Zhang D,Ku J,Yi Y,et al. The prognostic values of estrogen receptor alpha and beta in patients with gastroesophageal cancer:A meta-analysis[J]. Medicine (Baltimore),2019,98(46):e17954.
[16]	李明晖,武雪亮,王立坤,等. 某院结直肠肿瘤患者围术期营养风险筛查与营养支持的现状分析[J]. 重庆医学,2020,49(12):1919-1922. doi: 10.3969/j.issn.1671-8348.2020.12.006
[17]	马翠翠,李杨,庞向鹏,等. 胃癌,结直肠癌患者血清瘦素和脂联素变化及相关性分析[J]. 肿瘤代谢与营养电子杂志,2019,6(3):351-356.
[18]	Ghasemi A,Saeidi J,Azimi-Nejad M,et al. Leptin-induced signaling pathways in cancer cell migration and invasion[J]. Cell Oncol (Dordr),2019,42(3):243-260. doi: 10.1007/s13402-019-00428-0
[19]	Liu H,Luo J,Guillory B,et al. Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways[J]. Oncotarget,2020,11(35):3286-3302. doi: 10.18632/oncotarget.27705
[20]	苑小星. 脂质代谢异常与恶性肿瘤相关性研究进展[J]. 中国基层医药,2020,27(18):2300-2304. doi: 10.3760/cma.j.issn.1008-6706.2020.18.030
[21]	孙大勇. 血脂及脂蛋白代谢改变在胃癌中的临床意义[J]. 健康大视野,2019,(18):2. doi: 10.3969/j.issn.1005-0019.2019.18.002
[22]	Li T,Qian Y,Li H,et al. Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis[J]. Lipids Health Dis,2018,17(1):261. doi: 10.1186/s12944-018-0911-5
[23]	Kwon H J,Park M I,Park S J,et al. Insulin resistance is associated with early gastric cancer:a prospective multicenter case control study[J]. Gut Liver,2019,13(2):154-160. doi: 10.5009/gnl17556
[24]	Gupta A,Das A,Majumder K,et al. Obesity is independently associated with increased risk of hepatocellular cancer-related mortality:a systematic review and meta-analysis[J]. Am J Clin Oncol,2018,41(9):874-881. doi: 10.1097/COC.0000000000000388
[25]	那日苏,鲁秀玲. 胃癌患者血清中的细胞因子表达水平及血清APN、血脂检测的临床意义[J]. 世界最新医学信息文摘,2016,16(A0):161-162.
[26]	Tao S,Li L,Li L,et al. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy,type 2 diabetes mellitus and healthy controls:an analysis of the gut microbiota composition[J]. Acta Diabetol,2019,56(5):581-592. doi: 10.1007/s00592-019-01316-7
[27]	Li Z B,Han H F,Chang Y. Association between metabolic syndrome and the incidence of gastric cancer:a meta-analysis of cohort studies[J]. Diabetol Metab Syndr,2019,11(1):83.
[28]	Zhou X P,Rong- Hai H E,Quan H. Clinical characteristics analysis of senile patients with type 2 diabetes mellitus complicated with gastroesophageal reflux disease[J]. China Practical Med,2015,21(4):425-428.
[29]	Li F,Du H,Li S,et al. The association between metabolic syndrome and gastric cance r in chinese[J]. Frontiers in Oncology,2018,8(23):326.
[30]	张伟,黄少敏,黄炫杰,等. 2型糖尿病与消化系统恶性肿瘤的相关性分析[J]. 饮食保健,2018,5(50):34-35. doi: 10.3969/j.issn.2095-8439.2018.50.042
[31]	Gu J,Yan S,Wang B,et al. Type 2 diabetes mellitus and risk of gallbladder cancer:a systematic review and meta-analysis of observational studies[J]. Diabetes Metab Res Rev,2016,32(1):63-72. doi: 10.1002/dmrr.2671
[32]	安运锋,李霞,向月应,等. 代谢综合征与恶性肿瘤相关性研究进展[J]. 肿瘤代谢与营养电子杂志,2017,4(3):343-348.
[33]	Lu J,Zheng C H,Cao L L,et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients:A comparative study between the 7th and 8th editions[J]. Eur J Surg Oncol,2017,43(12):2349-2356. doi: 10.1016/j.ejso.2017.09.001
[34]	Sun L,Zhou P,Hua Q,et al. Effects of blood glucose,blood lipids and blood pressure control on recovery of patients with gastric cancer complicated with metabolic syndrome after radical gastrectomy[J]. Exp Ther Med,2018,15(6):4785-4790.
[35]	黄慧玲. 抗肿瘤治疗与高血压[J]. 中国医刊,2019,54(8):823-828. doi: 10.3969/j.issn.1008-1070.2019.08.004
[36]	Dovell F,Boffetta P. Serum uric acid and cancer mortality and incidence:a systematic review and meta-analysis[J]. Eur J Cancer Prev,2018,27(4):399-405. doi: 10.1097/CEJ.0000000000000440
[37]	苑小星,杨海芳. 血清尿酸及C反应蛋白与恶性实体肿瘤临床分期的关系[J]. 浙江医学,2019,41(13):1891-1894.
[38]	蒋传林,田山,董卫国. 高尿酸血症与胃癌预后关系的研究[J]. 实用癌症杂志,2019,34(2):207-210. doi: 10.3969/j.issn.1001-5930.2019.02.009
[39]	Yang J,Wang Y,Zhao Q,et al. Association of serum uric acid with increased risk of cancer among hypertensive chinese[J]. Int J Cancer,2017,141(1):112-120. doi: 10.1002/ijc.30731
[40]	潘理会,李育庄,李春辉. 胃癌与高凝血状态关系的研究现状[J]. 医学信息,2018,31(11):15-17,27. doi: 10.3969/j.issn.1006-1959.2018.11.005

相关文章(20)

[1]	曾慧娟, 田波, 袁红伶, 何杰, 李冠羲, 茹国佳, 许敏, 詹东. 机器学习算法构建慢性肾脏病伴高血压或糖尿病的预测模型, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240315
[2]	田波, 金永梅, 李海雯, 李重熙, 张伟, 关玮, 陈海云, 薛琪, 杨惠榕, 刘俊. 艾滋病抗病毒治疗患者代谢综合征发生现况及影响因素, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241121
[3]	张梁, 王保全, 雷喜锋, 王旭, 柯阳, 张玮. M2巨噬细胞来源的外泌体miR-1246调控胃癌细胞的生长和侵袭, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230724
[4]	牛玲, 李博一, 苗翠娟, 张程, 唐艳, 刘方, 马蓉. 瘦素、尿酸与2型糖尿病合并肥胖的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231121
[5]	何连菊, 左春梅, 刘岚, 崔文龙, 李锦波, 莫怡, 范卢明, 蔡乐. 云南富民县农村居民高血压的变化趋势及与肥胖指标的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211008
[6]	杨璐, 施文军, 赵玲, 杜士刚, 陈珮琪, 柯亭羽. 2型糖尿病患者内脏脂肪面积与肥胖及糖脂代谢指标的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210932
[7]	王华炜, 孟照辉, 陆亚南, 黄钊, 许君, 陈丽星. 云南西双版纳傣族农村居民高血压患病率及相关危险因素流行病学调查, 昆明医科大学学报.
[8]	乐小婧, 陈婕, 张帆, 李会芳. 代谢综合征与2型糖尿病的相关研究进展, 昆明医科大学学报.
[9]	苏晓杨, 赵豫梅, 念馨, 宋滇平. Meta分析2型糖尿病患者低碳水化合物饮食对体质指数及糖、脂代谢的影响, 昆明医科大学学报.
[10]	董玲, 彭云珠, 黄橙, 黄钊, 陈丽星. 云南大理白族高血压患病率及相关危险因素流行病学调查, 昆明医科大学学报.
[11]	朱荔, 丘红梅, 周晓芳, 蔡海刚, 刘开平, 周园媛. 血清CA19-9水平与2型糖尿病患者糖脂代谢的相关性, 昆明医科大学学报.
[12]	陈孝红, 王卓, 马婷, 马润, 李美玲, 周涛. vWF预测H型高血压患者血栓前状态的意义, 昆明医科大学学报.
[13]	李晓红, 马润玫, 陈卓. 肥胖、胰岛素抵抗对妊娠期糖尿病患者血清网膜素-1水平的影响, 昆明医科大学学报.
[14]	念馨. 金属硫蛋白基因G-201A多态性在2型糖尿病及原发性高血压的分布差异性, 昆明医科大学学报.
[15]	韩文菊, 牛奔, 梁赟, 段晓燕, 苏恒, 薛元明. 甲状腺功能正常的2型糖尿病甲状腺激素与嘌呤代谢和体重的相关性, 昆明医科大学学报.
[16]	龙琼华. 2型糖尿病对老年高血压患者颈动脉内膜中层厚度与左心室质量指数的影响及相关性, 昆明医科大学学报.
[17]	张利刚. 依那普利叶酸治疗H型高血压的临床效果观察, 昆明医科大学学报.
[18]	严小宏. CPAP对2型糖尿病合并阻塞性睡眠呼吸暂停综合征治疗观察, 昆明医科大学学报.
[19]	李显丽. 艾塞那肽治疗肥胖2型糖尿病的临床疗效观察, 昆明医科大学学报.
[20]	杨敏丽. 肥胖女大学生综合减肥方法探索及效果评价, 昆明医科大学学报.